This company has been marked as potentially delisted and may not be actively trading. Elicio Therapeutics (ELTX) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Elicio Therapeutics Earnings Summary Latest Q4 Earnings DateMar. 31EstimatedConsensus EPS (Mar. 31) -$0.94 Actual EPS (Mar. 31) -$1.02 Missed By -$0.08 Elicio Therapeutics posted Q4 2024 earnings on March 31, 2025, reporting an EPS of -$1.02, which missed the consensus estimate of -$0.94 by $0.08. With a trailing EPS of -$6.95, Elicio Therapeutics' earnings are expected to grow next year, from ($3.89) to ($3.62) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)Powered by Get Elicio Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elicio Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataELTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ELTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Elicio Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.70-$0.70-$0.70Q2 20251-$0.62-$0.62-$0.62Q3 20251-$0.63-$0.63-$0.63Q4 20251-$0.64-$0.64-$0.64FY 20254($2.59)($2.59)($2.59) Elicio Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/31/2025Q4 2024-$0.94-$1.02 -$0.08-$1.02--8/13/2024--$0.96-$0.64+$0.32-$0.64--5/15/2024Q1 2024-$1.09-$1.15 -$0.06-$1.15--3/29/2024Q4 2023--$3.77 -$3.77-$3.77--11/9/2023Q3 2023-$0.80-$1.27 -$0.47-$1.27--8/11/2023Q2 2023--$2.61 -$2.61-$2.61--5/10/2023Q1 2023-$5.40-$1.50+$3.90-$1.50-- Elicio Therapeutics Earnings - Frequently Asked Questions When did Elicio Therapeutics announce their last quarterly earnings? Elicio Therapeutics (NASDAQ:ELTX) last announced its quarterly earning data on Monday, March 31, 2025. Learn more on ELTX's earnings history. Did Elicio Therapeutics beat their earnings estimates last quarter? In the previous quarter, Elicio Therapeutics (NASDAQ:ELTX) missed the analysts' consensus estimate of ($0.94) by $0.08 with a reported earnings per share (EPS) of ($1.02). Learn more on analysts' earnings estimate vs. ELTX's actual earnings. How much revenue does Elicio Therapeutics generate each year? Elicio Therapeutics (NASDAQ:ELTX) has a recorded annual revenue of $2.30 million. How much profit does Elicio Therapeutics generate each year? Elicio Therapeutics (NASDAQ:ELTX) has a recorded net income of -$35.19 million. ELTX has generated -$6.95 earnings per share over the last four quarters. What is Elicio Therapeutics's EPS forecast for next year? Elicio Therapeutics's earnings are expected to grow from ($3.89) per share to ($3.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies Terns Pharmaceuticals Earnings Amarin Earnings Foghorn Therapeutics Earnings Esperion Therapeutics Earnings Gossamer Bio Earnings Design Therapeutics Earnings LifeVantage Earnings Eledon Pharmaceuticals Earnings TuHURA Biosciences Earnings Neurogene Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Markets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Market Anticipation Builds: Joby Stock Climbs Ahead of EarningsIs Intuitive Surgical a Buy After Volatile Reaction to Earnings?Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout This page (NASDAQ:ELTX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elicio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elicio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELTX Stock Free ELTX Stock Alerts